Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections: NADPH oxidase and BCG infection
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Infection of humans with Mycobacterium tuberculosis remains frequent and may still lead to death. After primary infection, the immune system is often able to control M. tuberculosis infection over a prolonged latency period, but a decrease in immune function (from HIV to immunosenescence) leads to active disease. Available vaccines against tuberculosis are restricted to BCG, a live vaccine with an attenuated strain of M. bovis. Immunodeficiency may not only be associated with an increased risk of tuberculosis, but also with local or disseminated BCG infection. Genetic deficiency in the reactive oxygen species (ROS)-producing phagocyte NADPH oxidase NOX2 is called chronic granulomatous disease (CGD). CGD is among the most common primary immune deficiencies. Here we review our knowledge on the importance of NOX2-derived ROS in mycobacterial infection. A literature review suggests that human CGD patient frequently have an increased susceptibility to BCG and to M. tuberculosis. In vitro studies and experiments with CGD mice are incomplete and yielded - at least in part - contradictory results. Thus, although observations in human CGD patients leave little doubt about the role of NOX2 in the control of mycobacteria, further studies will be necessary to unequivocally define and understand the role of ROS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Self-citationGutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., & Deretic, V. (2004) · Cell · doi:10.1016/j.cell.2004.11.038 · Cited by 2,252 · cited 1×
“It appears that autophagy, which is also driven by IFN-γ and TNF, is a mechanism to bypass the phagosome–lysosome block exerted by phagocytosed mycobacteria (Gutierrez et al., 2004).”
BackgroundGenome plasticity of BCG and impact on vaccine efficacy
Brosch, R., Gordon, S. V., Garnier, T., Eiglmeier, K., Frigui, W., Valenti, P., Dos Santos, S., Duthoy, S., Lacroix, C., Garcia-Pelayo, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700869104 · Cited by 574 · cited 1×
“However, there is clear evidence that circulating vaccine BCG strains have marked differences in their genome (Brosch et al., 2007), which might explain differences in efficacy, but possibly also Received 25 April, 2014; revised 3 June, 2014; accepted 6 June, 2014.”
BackgroundApoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis
Schaible, U. E., Winau, F., Sieling, P. A., Fischer, K., Collins, H. L., Hagens, K., Modlin, R. L., Brinkmann, V., & Kaufmann, S. H. E. (2003) · Nature Medicine · doi:10.1038/nm906 · Cited by 546 · cited 2×
“…death of infected macrophages stops mycobacterial replication (Placido et al., 2006) and (ii) uptake of mycobacteria-containing apoptotic bodies by dendritic cells might facilitate presentation of mycobacterial antigens and subsequent activation of adaptive immunity (Schaible et al., 2003).”
BackgroundMycobacterial survival strategies in the phagosome: defence against host stresses
Ehrt, S., & Schnappinger, D. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01335.x · Cited by 448 · cited 1×
“As macrophages produce ROS in response to mycobacterial infection, mycobacteria have developed strategies to cope with an oxidative environment, detoxifying ROS through various anti-oxidant mechanisms (Ehrt and Schnappinger, 2009).”
BackgroundParker, H., Dragunow, M., Hampton, M. B., Kettle, A. J., & Winterbourn, C. C. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211601 · Cited by 430 · cited 1×
“However, the importance of ROS in NET formation appears to depend on the stimulus (Parker et al., 2012).”
BackgroundSchaible, U. E., Sturgill-Koszycki, S., Schlesinger, P. H., & Russell, D. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1290 · Cited by 402 · cited 1×
“IFN-γ and TNF are key cytokines that lead to cell activation and enhanced phagosome–lysosome fusion in mycobacteria-infected macrophages (Schaible et al., 1998; Via et al., 1998).”
Backgroundde Luca, A., Smeekens, S. P., Casagrande, A., Iannitti, R., Conway, K. L., Gresnigt, M. S., Begun, J., Plantinga, T. S., Joosten, L. A. B., van der Meer, J. W. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322831111 · Cited by 313 · cited 1×
“It has also been suggested that overshooting IL-1β production in CGD patients is linked to decreased autophagy and that IL-1β inhibitor might therefore be beneficial to block inflammatory CGD complications (de Luca et al., 2014).”
BackgroundBustamante, J., Arias, A. A., Vogt, G., Picard, C., Galicia, L. B., Prando, C., Grant, A. V., Marchal, C. C., Hubeau, M., Chapgier, A., et al. (2011) · Nature Immunology · doi:10.1038/ni.1992 · Cited by 287 · cited 4×
“Along these lines is the recent discovery of a family with a peculiar variant of CGD with a lack ROS production in macrophages, but not in neutrophils (Bustamante et al., 2011a).”
BackgroundInfluentialLee, P. P. W., Chan, K.-W., Jiang, L., Chen, T., Li, C., Lee, T.-L., Mak, P. H. S., Fok, S. F. S., Yang, X., & Lau, Y.-L. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815b494c · Cited by 158 · cited 4×
“• Risk of BCG complications in CGD patients: retrospective studies estimate that between 6% and 57% of CGD patients will develop BCG complications if vaccinated (Mouy et al., 1989; Movahedi et al., 2004; Stasia et al., 2005; von Goessel et al., 2006; Lee et al., 2008; Teimourian et al., 2008; Bakri et al., 2009; van d…”
BackgroundInfluential
Cited by
Bustamante, J., Boisson-Dupuis, S., Abel, L., & Casanova, J.-L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.008 · Cited by 684
Reactive oxygen species and fibrosis: further evidence of a significant liaison
Richter, K., & Kietzmann, T. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2445-3 · Cited by 322
“The classic NOX from phagocytes forms a multiprotein complex, whereas the transmembrane proteins NOX2 (also known as gp91phox) and p22phox form the catalytic core for O2¯• production, which rapidly dismutates to hydrogen peroxide (Deffert et al. 2014; Nauseef 2014).”
BackgroundTo, K., Cao, R., Yegiazaryan, A., Owens, J., & Venketaraman, V. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082541 · Cited by 264
Köster, S., Upadhyay, S., Chandra, P., Papavinasasundaram, K., Yang, G., Hassan, A., Grigsby, S. J., Mittal, E., Park, H. S., Jones, V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707792114 · Cited by 208
NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs
Wen, Z., Shimojima, Y., Shirai, T., Li, Y., Ju, J., Yang, Z., Tian, L., Goronzy, J. J., & Weyand, C. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84181 · Cited by 146
Metadata
- Authors
- Deffert, C., Cachat, J., & Krause, K.-H.
- Venue
- Cellular Microbiology
- Publisher
- Hindawi Limited
- Published
- 2014-07-07
- Volume
- 16
- Issue
- 8
- Pages
- 1168-1178
- ISSN
- 1462-5814 (ISSN-L)
- OpenAlex
- W1531616236
- Cited by
- 123
- References
- 11
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections: NADPH oxidase and BCG infection. https://app.cochat.ai/papers/10.1111/cmi.12322
- The paper
- Deffert, C., Cachat, J., & Krause, K.-H. (2014). Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections: NADPH oxidase and BCG infection. Cellular Microbiology. https://doi.org/10.1111/cmi.12322
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.